The Senate voted 96-1 on Thursday to re-authorize the 1993 Prescription Drug User Fee Act, averting a downsizing of the FDA that could lengthen the approval process for getting important drugs and medical devices on the market.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=156363